- Latest Deal Type
- Financing Rounds
Prialt General Information
Developer of medicines designed to reduce severe chronic pain in adult patients. The company's medicines work on pain transmission by binding to the N-type calcium channels in the spinal cord that send pain signals enabling patients to reduce chronic pain.
- United States
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
Prialt Valuation & Funding
Prialt Former Investors
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|